Palvella Therapeutics (PVLA) Return on Sales Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Return on Sales Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | Palvella Therapeutics | 1.87 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -40.00 |
| Dec 31, 2023 | 85.00 |
| Sep 30, 2023 | 48.00 |
| Jun 30, 2023 | 56.00 |
| Mar 31, 2023 | -7.00 |
| Dec 31, 2022 | -89.00 |
| Sep 30, 2022 | -44.00 |
| Jun 30, 2022 | -33.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -5.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -23.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 4.00 |
| Sep 30, 2020 | -5.00 |
| Jun 30, 2020 | 2.00 |
| Mar 31, 2020 | 1.00 |
| Dec 31, 2019 | 19.00 |